An app made by two Swedish doctors has helped 5,000 women get pregnant, its creators have announced.
The app, called Natural Cycles and created by husband and wife team Dr Elina Berglund and Dr Raoul Scherwitzl, has been shown to be as effective as the contraceptive pill and can pinpoint ovulation with the same accuracy as methods used in clinics and hospitals. It is also the first health app for women to be regulated as a medical device.
Natural Cycles works by identifying a woman’s ovulation and fertile window by tracking her period and temperature. Women are required to record the temperature under their tongue in the morning and enter it into the app, which uses a unique algorithm to determine whether they are fertile on that day.
Now, Dr Berglund, a physicist who was part of the Nobel Prize-winning team that discovered the Higgs boson, is so confident about its new #HappyPregnancy campaign that the start-up is offering to refund women in the UK if they don’t conceive in the first nine months of use.
“The success of Natural Cycles depends on its algorithm,” said Dr Berglund. “We’ve called the algorithm ‘Alba’ (after our daughter) and it’s unique because it has collected data from hundreds of thousands of cycles. This means Natural Cycles can adapt to each individual woman’s body and, with a high degree of precision and accuracy, determine when she is ovulating.
“Natural Cycles is a great example of how technology is helping women to conceive in an easy and accessible way. We know we’re dealing with women’s lives here and we take that very seriously. The app can also be used for infertile couples to identify the cause of infertility. We’ve helped over 5,000 women in Sweden get ‘#HappyPregnant’ and hope to achieve the same success with women in the UK.”
Click here to access Natural Cycles and for more details about #HappyPregnancy
Launched in 2014 and headquartered in Stockholm, Sweden, Natural Cycles has more than 100,000 active users in 161 countries. In 2016, the company raised $6 million funding to conduct new clinical studies and aid international expansion, and donated $25 million worth of free subscriptions to women in Brazil to help fight the Zika virus.